CITED2 and Obesity: In this study, our analyses show that myeloid-CITED2 deficiency promotes HFD-induced adipose tissue inflammation, adverse remodeling of adipocytes, expansion of adipose tissue volume, obesity, insulin resistance, and glucose intolerance.